Detailansicht

Wissensnetz

Person

Lucie Heinzerling (1969-)

Name	Lucie Heinzerling
Zeit	1969- (Lebensdaten)
Ort	München (Geburtsort) Deutschland
Variante	L. Heinzerling
Weitere Angaben	Habil.-Schr., Fachbereich Dermatologie und Venerologie
Datensatztyp	Person
GND-Nummer	124732755
Datensatz-ID	124732755
Beteiligt an alle anzeigen Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) Model soups improve performance of dermoscopic skin cancer classifiers Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG) Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG) Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study Medikamentöse Tumortherapie in der Dermato-Onkologie Medikamentöse Tumortherapie in der Dermato-Onkologie A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival Medikamentöse Tumortherapie in der Dermato-Onkologie : mit 57 Tabellen Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls The skin prick test – European standards Immuntherapie des Melanoms mit Plasmid-DNA : Erkenntnisse aus der präklinischen und klinischen Forschung Studie zu den immunologischen Wirkmechanismen eines standardisierten Mistelextraktes auf die Funktion von humanen Monozyten und Lymphozyten in vitro, ex vivo und in vivo

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Lucie Heinzerling (1969-)

Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective

Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity

Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)

Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial)

Model soups improve performance of dermoscopic skin cancer classifiers

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Medikamentöse Tumortherapie in der Dermato-Onkologie

Medikamentöse Tumortherapie in der Dermato-Onkologie

A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival

Medikamentöse Tumortherapie in der Dermato-Onkologie : mit 57 Tabellen

Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls

The skin prick test – European standards

Immuntherapie des Melanoms mit Plasmid-DNA : Erkenntnisse aus der präklinischen und klinischen Forschung

Studie zu den immunologischen Wirkmechanismen eines standardisierten Mistelextraktes auf die Funktion von humanen Monozyten und Lymphozyten in vitro, ex vivo und in vivo